Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MB, Bos JD, Tak PP. Goedkoop AY, et al. Among authors: bos jd. Arthritis Res Ther. 2004;6(4):R326-34. doi: 10.1186/ar1182. Epub 2004 May 26. Arthritis Res Ther. 2004. PMID: 15225368 Free PMC article.
Overview of psoriasis.
de Rie MA, Goedkoop AY, Bos JD. de Rie MA, et al. Among authors: bos jd. Dermatol Ther. 2004;17(5):341-9. doi: 10.1111/j.1396-0296.2004.04037.x. Dermatol Ther. 2004. PMID: 15379769 Review.
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor.
de Groot M, Teunissen MB, Ortonne JP, Lambert JR, Naeyaert JM, Picavet DI, Arreaza MG, Simon JS, Kraan M, Bos JD, de Rie MA. de Groot M, et al. Among authors: bos jd. Arch Dermatol Res. 2007 Sep;299(7):305-13. doi: 10.1007/s00403-007-0764-7. Epub 2007 Jul 24. Arch Dermatol Res. 2007. PMID: 17647003 Free PMC article. Clinical Trial.
Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
Piskin G, Heydendael VM, de Rie MA, Bos JD, Teunissen MB. Piskin G, et al. Among authors: bos jd. Arch Dermatol Res. 2003 Mar;294(12):559-62. doi: 10.1007/s00403-002-0353-8. Epub 2002 Dec 14. Arch Dermatol Res. 2003. PMID: 12624782 Clinical Trial. No abstract available.
The burden of psoriasis is not determined by disease severity only.
Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. Heydendael VM, et al. Among authors: bos jd. J Investig Dermatol Symp Proc. 2004 Mar;9(2):131-5. doi: 10.1111/j.1087-0024.2004.09115.x. J Investig Dermatol Symp Proc. 2004. PMID: 15083779 Free article. Clinical Trial.
337 results